GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cell Biotech Co Ltd (XKRX:049960) » Definitions » Cyclically Adjusted PS Ratio

Cell Biotech Co (XKRX:049960) Cyclically Adjusted PS Ratio : 1.60 (As of Jun. 05, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Cell Biotech Co Cyclically Adjusted PS Ratio?

As of today (2025-06-05), Cell Biotech Co's current share price is ₩13080.00. Cell Biotech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩8,166.64. Cell Biotech Co's Cyclically Adjusted PS Ratio for today is 1.60.

The historical rank and industry rank for Cell Biotech Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:049960' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.38   Med: 2.9   Max: 11.88
Current: 1.58

During the past years, Cell Biotech Co's highest Cyclically Adjusted PS Ratio was 11.88. The lowest was 1.38. And the median was 2.90.

XKRX:049960's Cyclically Adjusted PS Ratio is ranked better than
77.87% of 497 companies
in the Biotechnology industry
Industry Median: 5.61 vs XKRX:049960: 1.58

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cell Biotech Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ₩1,638.297. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩8,166.64 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cell Biotech Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Cell Biotech Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell Biotech Co Cyclically Adjusted PS Ratio Chart

Cell Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.87 2.85 1.74 1.43 1.77

Cell Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.51 1.64 1.72 1.77 1.54

Competitive Comparison of Cell Biotech Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Cell Biotech Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Biotech Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cell Biotech Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cell Biotech Co's Cyclically Adjusted PS Ratio falls into.


;
;

Cell Biotech Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cell Biotech Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=13080.00/8166.64
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Biotech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Cell Biotech Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1638.297/122.5900*122.5900
=1,638.297

Current CPI (Mar. 2025) = 122.5900.

Cell Biotech Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1,728.562 100.051 2,117.970
201509 1,841.568 100.111 2,255.080
201512 1,545.764 100.220 1,890.785
201603 2,039.673 100.561 2,486.488
201606 1,645.093 100.791 2,000.898
201609 1,534.358 101.461 1,853.881
201612 1,960.962 101.561 2,366.988
201703 1,906.103 102.851 2,271.928
201706 2,307.447 102.611 2,756.713
201709 1,952.395 103.491 2,312.716
201712 1,923.711 102.991 2,289.794
201803 2,114.103 104.101 2,489.586
201806 2,175.377 104.130 2,561.017
201809 1,951.728 105.651 2,264.659
201812 2,092.465 104.351 2,458.204
201903 1,515.165 104.491 1,777.610
201906 1,549.881 104.881 1,811.578
201909 1,401.584 105.200 1,633.267
201912 1,729.572 105.121 2,016.986
202003 1,701.778 105.354 1,980.187
202006 1,598.677 105.112 1,864.508
202009 1,579.482 106.198 1,823.287
202012 1,545.519 105.765 1,791.372
202103 1,503.832 107.357 1,717.209
202106 1,618.155 107.579 1,843.951
202109 1,803.552 108.759 2,032.908
202112 1,700.356 109.676 1,900.561
202203 1,745.137 111.848 1,912.742
202206 1,769.880 114.072 1,902.036
202209 1,802.828 114.715 1,926.584
202212 2,001.088 115.179 2,129.841
202303 1,875.155 116.507 1,973.053
202306 1,815.083 117.182 1,898.848
202309 1,997.345 118.964 2,058.231
202312 2,163.264 118.837 2,231.580
202403 1,906.946 120.123 1,946.106
202406 1,835.373 120.007 1,874.872
202409 1,782.015 120.861 1,807.505
202412 1,775.231 121.135 1,796.551
202503 1,638.297 122.590 1,638.297

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cell Biotech Co  (XKRX:049960) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cell Biotech Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Cell Biotech Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cell Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
134 Gaegok-ri, Wolgot-myeon, Gimpo-si, Gyeonggi-Do, KOR, 415-872
Cell Biotech Co Ltd is a specialized biotech company. It is engaged in the fermentation and coating technology development as well as manufacturing probiotics and lactic acid bacteria. The key product consists Probiotic DUOLAC, Nutra DUOLAC, LACTOClear, and LAB2PRO. The company distributes its products within domestic market and to overseas markets.

Cell Biotech Co Headlines

No Headlines